Editorial
Hypothyroidism, Hypertension and Breast Cancer: Scientific Insights
Amani E Khalifa*
Faculty of Pharmacy, Ain Shams University and Scientific Consultant for Children Cancer Hospital (CCHE 57357), Cairo, Egypt
Amani E Khalifa, Professor of Pharmacology & Toxicology, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.
Received Date: August 05, 2018; Published Date: August 20, 2018
Abstract
Subclinical hypothyroidism is an early stage of hypothyroidism and is usually manifested as elevated thyrotropin-stimulating hormone (TSH) and normal free thyroxine (T4) levels. In such cases, clinical symptoms are usually not manifested although some cases may have minor/subtle symptoms of hypothyroidism and may have mild abnormalities of serum lipoproteins and cardiac function. This condition may resolve, remain unchanged, or develop into overt hypothyroidism within few years, with low free T4 levels as well as a raised TSH level. The likelihood that this will happen increases with greater TSH elevations and detectable antithyroid antibodies [1-5].
-
Amani E Khalifa. Hypothyroidism, Hypertension and Breast Cancer: Scientific Insights. Adv Can Res & Clinical Imag. 1(1): 2018. ACRCI.MS.ID.000501.
-
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.